IRHYTHM HOLDINGS INC (IRTC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IRTC • US4500561067

152.22 USD
+3.72 (+2.51%)
At close: Feb 10, 2026
152.22 USD
0 (0%)
After Hours: 2/10/2026, 4:30:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

IRTC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. IRTC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IRTC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • IRTC had negative earnings in the past year.
  • IRTC had a positive operating cash flow in the past year.
  • IRTC had negative earnings in each of the past 5 years.
  • In the past 5 years IRTC reported 4 times negative operating cash flow.
IRTC Yearly Net Income VS EBIT VS OCF VS FCFIRTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • The Return On Assets of IRTC (-5.17%) is better than 66.67% of its industry peers.
  • The Return On Equity of IRTC (-42.22%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.17%
ROE -42.22%
ROIC N/A
ROA(3y)-22.19%
ROA(5y)-19.41%
ROE(3y)-77.27%
ROE(5y)-56.18%
ROIC(3y)N/A
ROIC(5y)N/A
IRTC Yearly ROA, ROE, ROICIRTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • IRTC's Gross Margin of 70.35% is fine compared to the rest of the industry. IRTC outperforms 79.57% of its industry peers.
  • In the last couple of years the Gross Margin of IRTC has declined.
  • The Profit Margin and Operating Margin are not available for IRTC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y-1.83%
IRTC Yearly Profit, Operating, Gross MarginsIRTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • IRTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IRTC has more shares outstanding than it did 1 year ago.
  • IRTC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IRTC has a worse debt to assets ratio.
IRTC Yearly Shares OutstandingIRTC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IRTC Yearly Total Debt VS Total AssetsIRTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.32 indicates that IRTC is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of IRTC (3.32) is better than 71.51% of its industry peers.
  • IRTC has a debt to FCF ratio of 20.01. This is a negative value and a sign of low solvency as IRTC would need 20.01 years to pay back of all of its debts.
  • The Debt to FCF ratio of IRTC (20.01) is better than 69.89% of its industry peers.
  • A Debt/Equity ratio of 5.32 is on the high side and indicates that IRTC has dependencies on debt financing.
  • IRTC has a Debt to Equity ratio of 5.32. This is amonst the worse of the industry: IRTC underperforms 84.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.32
Debt/FCF 20.01
Altman-Z 3.32
ROIC/WACCN/A
WACC9.53%
IRTC Yearly LT Debt VS Equity VS FCFIRTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • IRTC has a Current Ratio of 4.63. This indicates that IRTC is financially healthy and has no problem in meeting its short term obligations.
  • IRTC's Current ratio of 4.63 is fine compared to the rest of the industry. IRTC outperforms 75.27% of its industry peers.
  • A Quick Ratio of 4.50 indicates that IRTC has no problem at all paying its short term obligations.
  • IRTC has a better Quick ratio (4.50) than 80.11% of its industry peers.
Industry RankSector Rank
Current Ratio 4.63
Quick Ratio 4.5
IRTC Yearly Current Assets VS Current LiabilitesIRTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 69.72% over the past year.
  • IRTC shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.45%.
  • Measured over the past years, IRTC shows a very strong growth in Revenue. The Revenue has been growing by 22.49% on average per year.
EPS 1Y (TTM)69.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.24%
Revenue 1Y (TTM)25.45%
Revenue growth 3Y22.39%
Revenue growth 5Y22.49%
Sales Q2Q%30.74%

3.2 Future

  • IRTC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.66% yearly.
  • The Revenue is expected to grow by 18.45% on average over the next years. This is quite good.
EPS Next Y59.19%
EPS Next 2Y37.71%
EPS Next 3Y30.66%
EPS Next 5Y23.66%
Revenue Next Year26.39%
Revenue Next 2Y21.65%
Revenue Next 3Y19.55%
Revenue Next 5Y18.45%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IRTC Yearly Revenue VS EstimatesIRTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
IRTC Yearly EPS VS EstimatesIRTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • IRTC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRTC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRTC Price Earnings VS Forward Price EarningsIRTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IRTC indicates a somewhat cheap valuation: IRTC is cheaper than 68.28% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 151.28
EV/EBITDA N/A
IRTC Per share dataIRTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IRTC's earnings are expected to grow with 30.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.71%
EPS Next 3Y30.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IRTC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IRHYTHM HOLDINGS INC

NASDAQ:IRTC (2/10/2026, 4:30:02 PM)

After market: 152.22 0 (0%)

152.22

+3.72 (+2.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12
Earnings (Next)04-29
Inst Owners109.39%
Inst Owner Change0.17%
Ins Owners0.8%
Ins Owner Change-0.41%
Market Cap4.90B
Revenue(TTM)702.57M
Net Income(TTM)-51.46M
Analysts85.45
Price Target224.6 (47.55%)
Short Float %8.66%
Short Ratio5.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.57%
Min EPS beat(2)34.09%
Max EPS beat(2)81.05%
EPS beat(4)4
Avg EPS beat(4)55.92%
Min EPS beat(4)4.68%
Max EPS beat(4)103.85%
EPS beat(8)5
Avg EPS beat(8)0.84%
EPS beat(12)6
Avg EPS beat(12)-2.68%
EPS beat(16)10
Avg EPS beat(16)2.64%
Revenue beat(2)2
Avg Revenue beat(2)3.79%
Min Revenue beat(2)2.36%
Max Revenue beat(2)5.22%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.42%
Max Revenue beat(4)5.22%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)8
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)0.93%
PT rev (1m)0.73%
PT rev (3m)14%
EPS NQ rev (1m)-5.08%
EPS NQ rev (3m)-28.27%
EPS NY rev (1m)0%
EPS NY rev (3m)14.32%
Revenue NQ rev (1m)0.9%
Revenue NQ rev (3m)0.9%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.98
P/FCF 151.28
P/OCF 66.38
P/B 40.24
P/tB 40.52
EV/EBITDA N/A
EPS(TTM)-1.32
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)1.01
FCFY0.66%
OCF(TTM)2.29
OCFY1.51%
SpS21.81
BVpS3.78
TBVpS3.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.17%
ROE -42.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.35%
FCFM 4.61%
ROA(3y)-22.19%
ROA(5y)-19.41%
ROE(3y)-77.27%
ROE(5y)-56.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y-1.83%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 5.32
Debt/FCF 20.01
Debt/EBITDA N/A
Cap/Depr 199.56%
Cap/Sales 5.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.63
Quick Ratio 4.5
Altman-Z 3.32
F-Score6
WACC9.53%
ROIC/WACCN/A
Cap/Depr(3y)235.33%
Cap/Depr(5y)237.52%
Cap/Sales(3y)7.91%
Cap/Sales(5y)7.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.24%
EPS Next Y59.19%
EPS Next 2Y37.71%
EPS Next 3Y30.66%
EPS Next 5Y23.66%
Revenue 1Y (TTM)25.45%
Revenue growth 3Y22.39%
Revenue growth 5Y22.49%
Sales Q2Q%30.74%
Revenue Next Year26.39%
Revenue Next 2Y21.65%
Revenue Next 3Y19.55%
Revenue Next 5Y18.45%
EBIT growth 1Y44.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.3%
EBIT Next 3Y49.15%
EBIT Next 5Y33.14%
FCF growth 1Y158.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y442.85%
OCF growth 3YN/A
OCF growth 5YN/A

IRHYTHM HOLDINGS INC / IRTC FAQ

What is the ChartMill fundamental rating of IRHYTHM HOLDINGS INC (IRTC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IRTC.


Can you provide the valuation status for IRHYTHM HOLDINGS INC?

ChartMill assigns a valuation rating of 2 / 10 to IRHYTHM HOLDINGS INC (IRTC). This can be considered as Overvalued.


What is the profitability of IRTC stock?

IRHYTHM HOLDINGS INC (IRTC) has a profitability rating of 2 / 10.


What is the expected EPS growth for IRHYTHM HOLDINGS INC (IRTC) stock?

The Earnings per Share (EPS) of IRHYTHM HOLDINGS INC (IRTC) is expected to grow by 59.19% in the next year.